MétaCan
Menu
Back to cohort
Record W4221036244 · doi:10.1002/ejhf.2493

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

2022· review· en· W4221036244 on OpenAlexaff
Arantxa González, Mark Richards, Rudolf A. de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcão‐Pires, Javier Dı́ez, Roger Foo, Mark Y. Chan, Alberto Aimo, Chukwuemeka George Anene-Nzelu, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D. Anker, Yuri Belenkov, Tuvia Ben Gal, Alain Cohen‐Solal, Michael Böhm, Ovidiu Chioncel, Victoria Delgado, Michele Emdin, Ewa A. Jankowska, Finn Gustafsson, Loreena Hill, Tiny Jaarsma, James L. Januzzi, Pardeep S. Jhund, Yu. M. Lopatin, Lars H. Lund, Marco Metra, Davor Milicić, Brenda Moura, Christian Mueller, Wilfried Müllens, Julio Núñez, Massimo Piepoli, Amina Rakisheva, Arsen Ristić, Patrick Rossignol, Gianluigi Savarese, Carlo G. Tocchetti, Sophie Van Linthout, Maurizio Volterrani, Petar Seferović, Giuseppe Rosano, Andrew J.S. Coats, Antoni Bayés‐Genís

Bibliographic record

VenueEuropean Journal of Heart Failure · 2022
Typereview
Languageen
FieldMedicine
TopicCardiac Fibrosis and Remodeling
Canadian institutionsSurgical Specialties (Canada)Montreal Heart Institute
FundersRelypsaEuropean Regional Development FundNational Medical Research CouncilAbbott VascularServierUniversitair Medisch Centrum GroningenMedical Research CouncilLeids Universitair Medisch CentrumMyoKardiaNovo NordiskIdorsia PharmaceuticalsKarolinska InstitutetHorizon 2020 Framework ProgrammeStockholms Läns LandstingHealth Research Council of New ZealandUniversiteit LeidenDeutsche ForschungsgemeinschaftNational Heart Foundation of New ZealandFondation LeducqVetenskapsrådetFresenius Medical Care North AmericaCytokineticsAmicus TherapeuticsIonis PharmaceuticalsInstituto de Salud Carlos IIIAmgenEuropean Society of CardiologyBoston Scientific CorporationEdwards LifesciencesBayer HealthCareEuropean CommissionSanofiMinisterio de Ciencia, Innovación y UniversidadesAstraZenecaPfizer
KeywordsMedicineHeart failureVascular remodelling in the embryoVentricleVentricular remodelingInternal medicineCardiologyBiomarkerBiology

Abstract

fetched live from OpenAlex

Cardiac remodelling refers to changes in left ventricular structure and function over time, with a progressive deterioration that may lead to heart failure (HF) development (adverse remodelling) or vice versa a recovery (reverse remodelling) in response to HF treatment. Adverse remodelling predicts a worse outcome, whilst reverse remodelling predicts a better prognosis. The geometry, systolic and diastolic function and electric activity of the left ventricle are affected, as well as the left atrium and on the long term even right heart chambers. At a cellular and molecular level, remodelling involves all components of cardiac tissue: cardiomyocytes, fibroblasts, endothelial cells and leucocytes. The molecular, cellular and histological signatures of remodelling may differ according to the cause and severity of cardiac damage, and clearly to the global trend toward worsening or recovery. These processes cannot be routinely evaluated through endomyocardial biopsies, but may be reflected by circulating levels of several biomarkers. Different classes of biomarkers (e.g. proteins, non-coding RNAs, metabolites and/or epigenetic modifications) and several biomarkers of each class might inform on some aspects on HF development, progression and long-term outcomes, but most have failed to enter clinical practice. This may be due to the biological complexity of remodelling, so that no single biomarker could provide great insight on remodelling when assessed alone. Another possible reason is a still incomplete understanding of the role of biomarkers in the pathophysiology of cardiac remodelling. Such role will be investigated in the first part of this review paper on biomarkers of cardiac remodelling.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.188
Threshold uncertainty score0.996

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0090.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.281
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations68
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of Heart FailureSame topicCardiac Fibrosis and RemodelingFrench-language works237,207